| Dr Jade Matthew Reynolds, DC | |
|
430 Wind Ridge Trl, Berne, IN 46711-2375 | |
| (260) 589-3256 | |
| (260) 589-3587 |
| Full Name | Dr Jade Matthew Reynolds |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 21 Years |
| Location | 430 Wind Ridge Trl, Berne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003874645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 08002103A (Indiana) | Primary |
| Provider Name | Reynolds Chiropractic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477715373 PECOS PAC ID: 3072672492 Enrollment ID: O20081030000117 |
News Archive
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
The global fight against antimicrobial resistance could be under threat unless the evidence base for policies to control resistance is radically improved, according to a major new Series, published in The Lancet.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jade Matthew Reynolds, DC 430 Wind Ridge Trl, Berne, IN 46711-2375 Ph: (260) 589-3256 | Dr Jade Matthew Reynolds, DC 430 Wind Ridge Trl, Berne, IN 46711-2375 Ph: (260) 589-3256 |
News Archive
Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.
Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
The global fight against antimicrobial resistance could be under threat unless the evidence base for policies to control resistance is radically improved, according to a major new Series, published in The Lancet.
Therakos, Inc., a pioneer in the innovative treatment of extracorporeal photopheresis (ECP) for immune modulation therapy, today announced that the first patient has been enrolled in its Phase IIb clinical study evaluating the use of the company's photopheresis technology in the treatment of patients with moderate-to-severe chronic Graft-versus-Host Disease (GvHD).
› Verified 2 days ago
Reynolds Chiropractic Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 430 Wind Ridge Trl, Berne, IN 46711 Phone: 260-589-3256 Fax: 260-589-3587 |